Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Active Biotech AB ( (SE:ACTI) ) is now available.
Active Biotech AB has called its annual general meeting for May 20, 2026, in Lund, setting the record date for shareholder participation at May 11 and confirming that it has 2,636,067,170 shares outstanding. The board proposes that no dividend be paid and that the accumulated loss be carried forward, underscoring a continued focus on conserving capital.
The company’s election committee recommends keeping a three-member board, with the re-election of Michael Shalmi, Peter Thelin, and Aleksandar Danilovski, and proposes Shalmi as chairman. It also recommends reappointing Öhrlings PricewaterhouseCoopers AB as auditor, while former board members Uli Hacksell and Axel Glasmacher have declined re-election, signaling a modest refresh of the company’s governance structure.
More about Active Biotech AB
Active Biotech AB is a Sweden-based biotechnology company headquartered in Lund. The company focuses on developing pharmaceutical products, with its operations and governance overseen by a board of directors and audited by Öhrlings PricewaterhouseCoopers AB.
YTD Price Performance: 54.35%
Average Trading Volume: 24,715,826
Technical Sentiment Signal: Sell
Current Market Cap: SEK188.5M
Learn more about ACTI stock on TipRanks’ Stock Analysis page.